Introduction
Mechanisms of substitution and complementation
-
Early detection of an illness in outpatient care can make treatment possible at that level and obviate the need for hospitalization. This substitution mechanism, they claim, could have both short-term (e.g. prevention of hospitalization for asthma by prevention and early treatment of exacerbations) and long-term effects (e.g. prevention of stroke by the treatment of hypertension).
-
The management of chronic health conditions in outpatient care (e.g. routine testing or patient education) can also prevent or at least delay the need for inpatient care—control of blood sugar to avert kidney failure in patients with diabetes mellitus is a classic example of this.
-
Depending on the rules and incentives built into the health care system of the country in question, doctors in outpatient care could have a formal gate-keeping role, as well: in many cases, their referral can be required for hospitalization.
-
Treatment in outpatient care might call for supplemental or ancillary care provided in hospitals (e.g. diagnostic laboratory tests).
-
The detection in outpatient care of illnesses (e.g. cancer, serious mental illness) that are best treated by a specialist, in hospital. This mechanism could especially affect patients who have not used primary care services for a long period of time and who have a greater number of undetected illnesses.
-
The identification (through close monitoring) of acute episodes of chronic illnesses that require specialty or inpatient treatment. This mechanism is particularly relevant for disorders with symptoms that may fluctuate in severity over time (e.g. angina or major depressive disorder).
Institutional context
Data and descriptive statistics
-
cardiology-related conditions (angina, congestive heart failure, and hypertension) (0.8%),
-
pulmonology-related conditions (asthma and COPD) (0.6%),
-
diabetes complications (0.3%),
-
conditions due to non-adequate specialist outpatient care (e.g. ear, nose, and throat infection) (0.3%), and
-
conditions due to non-adequate primary care (e.g. influenza) (0.6%).
Methods
Effects of the new outpatient locations
-
FE linear models on inpatient and outpatient expenditures of person i in year t.
-
first, the treatment dummy is interacted with gender and age groups to examine potential heterogeneity across these categories;
-
second, the treatment dummy is interacted with the indicators of local supply of inpatient care such as the travel time between the micro-region and the nearest (substantial) hospital7 or the capacity utilization rate of the beds in the nearest hospital;
-
third, the (changing) travel time to the nearest outpatient service location is used as an additional explanatory variable beyond the treatment dummy to examine the effects of the heterogenous improvement in outpatient availability across settlements.
Substitution between outpatient and inpatient care
Results
Probabilities | Case numbers | |||||||
---|---|---|---|---|---|---|---|---|
Baseline (%) | FE logit | Baseline (/100) | FE Poisson | FE linear | ||||
Odds ratio | Multipl. effect | Effect (per 100) | ||||||
Est. | SE | Est. | SE | Est. | SE | |||
Inpatient care | ||||||||
Overall | 13.3 | 0.985** | (0.006) | 21.3 | 0.984** | (0.006) | − 0.63*** | (0.12) |
Not PAH | 11.9 | 0.998 | (0.006) | 18.4 | 0.991 | (0.007) | − 0.38*** | (0.12) |
PAH | 2.4 | 0.932*** | (0.012) | 2.9 | 0.950*** | (0.013) | − 0.25*** | (0.033) |
Cardiology | 0.80 | 0.906*** | (0.019) | 0.93 | 0.909*** | (0.020) | − 0.095*** | (0.018) |
Pulmonology | 0.58 | 1.005 | (0.027) | 0.74 | 1.035 | (0.030) | − 0.066*** | (0.017) |
Diabetes | 0.27 | 0.934** | (0.032) | 0.31 | 0.945 | (0.033) | − 0.017* | (0.011) |
Spec. care spec. | 0.31 | 0.932** | (0.030) | 0.32 | 0.935* | (0.033) | − 0.021** | (0.010) |
Prim. care spec. | 0.59 | 0.981 | (0.024) | 0.61 | 0.975 | (0.027) | − 0.047*** | (0.014) |
Outpatient care | ||||||||
Overall non-lab. | 54.6 | 1.232*** | (0.005) | 293.0 | 1.185*** | (0.004) | 53.0*** | (0.94) |
Cardiology | 5.8 | 1.290*** | (0.011) | 11.0 | 1.209*** | (0.011) | 2.8*** | (0.11) |
Pulmonology | 4.2 | 1.203*** | (0.013) | 8.7 | 1.043*** | (0.012) | 0.25** | (0.097) |
Diabetes | 2.3 | 1.325*** | (0.025) | 5.3 | 1.204*** | (0.015) | 1.2*** | (0.073) |
Overall lab. | 31.4 | 1.107*** | (0.005) | 105.0 | 1.148*** | (0.006) | 17.0*** | (0.55) |
Cardiology | 1.7 | 2.586*** | (0.037) | 2.9 | 1.786*** | (0.035) | 2.8*** | (0.065) |
Pulmonology | 0.33 | 1.349*** | (0.050) | 0.70 | 1.126** | (0.060) | − 0.16*** | (0.030) |
Diabetes | 0.76 | 3.118*** | (0.079) | 1.4 | 2.038*** | (0.050) | 1.2*** | (0.036) |
Expenditures | ||||||||
---|---|---|---|---|---|---|---|---|
Baseline (1000 HUF) | FE linear | |||||||
Effect | SE | |||||||
Inpatient | 32.6 | − 0.82*** | (0.26) | |||||
Outpatient | 9.9 | 1.28*** | (0.040) |
Inpatient care
Outpatient care
Heterogeneity and robustness checks
Probabilities | Case numbers | |||
---|---|---|---|---|
FE logit | FE Poisson | |||
Odds ratio | Multipl. effect | |||
Inpatient care | Est. | SE | Est. | SE |
Overall | 0.984*** | (0.003) | 0.991*** | (0.003) |
Not PAH | 0.989*** | (0.003) | 0.993* | (0.004) |
PAH | 0.965*** | (0.007) | 0.980*** | (0.007) |
Cardiology | 0.957*** | (0.012) | 0.958*** | (0.013) |
Pulmonology | 0.996 | (0.014) | 1.021 | (0.014) |
Diabetes | 0.959** | (0.019) | 0.949*** | (0.020) |
Specialist care specific | 0.974 | (0.018) | 0.971 | (0.020) |
Primary care specific | 0.961* | (0.013) | 0.983 | (0.016) |
Dynamic effects
Substitution between outpatient and inpatient care
Parameter | Lagged parameter | |||
---|---|---|---|---|
Est. | SE | Est. | SE | |
Dependent var.: inpatient case number | ||||
Endogenous explanatory var: | ||||
Outpatient case number | − 0.010*** | (0.0034) | ||
Outpatient case number and its lag | − 0.0058 | (0.0035) | − 0.013*** | (0.0033) |
Dependent var.: inpatient expenditure | ||||
Endogenous explanatory var: | ||||
Outpatient expenditure | − 0.642*** | (0.215) | ||
Outpatient expenditure and its lag | − 0.292 | (0.356) | − 0.511* | (0.284) |